Uridine-cytidine kinase 2 is correlated with immune, DNA damage repair and promotion of cancer stemness in pan-cancer

Uridine-cytidine kinase 2 is correlated with immune, DNA damage repair and promotion of cancer stemness in pan-cancer

BackgroundUCK2 (Uridine-Cytidine Kinase 2) is a promising prognostic marker for malignant tumors, but its association with immune infiltration and cancer stemness in pan-cancer remains to be fully understood. we find that gene UCK2 is closed related to RNA stemness scores (RNAss) and DNA stemness sc...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jinlong Tian, Yanlei Li, Yu Tong, Yuan Zhang, Tingxiao Zhao, Yao Kang, Qing Bi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Oncology
Subjects:	pan-cancer uridine-cytidine kinase 2 DNA mismatch repair (MMR) homologous recombination repair (HRR) cancer stemness immune
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1503300/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A case of de novo neuroendocrine prostate cancer presented with elevated level of serum CEA carrying BRCA2 mutation: case report and literature review
by: Weizhe Han, et al.
Published: (2025-01-01)

Lynch syndrome screening in colorectal and endometrial cancers in Iceland
by: Katla R. Kluvers, et al.
Published: (2025-01-01)

DMMR status and synchronous lesions predicts metachronous lesions after curative resection for rectal cancer
by: Xijie Chen, et al.
Published: (2025-01-01)

Repression of PFKFB3 sensitizes ovarian cancer to PARP inhibitors by impairing homologous recombination repair
by: Yinan Xiao, et al.
Published: (2025-01-01)

Tousled-like kinase loss confers PARP inhibitor resistance in BRCA1-mutated cancers by impeding non-homologous end joining repair
by: Min-ah Kim, et al.
Published: (2025-01-01)

PARP inhibitor‐based treatment in metastatic, castration‐resistant prostate cancer (mCRPC): A systematic review and meta‐analysis
by: Michela Roberto, et al.
Published: (2025-01-01)

Durable Clinical Benefit after Dual Checkpoint Inhibition and Single-agent Nivolumab Following Pembrolizumab Failure in Mismatch Repair-deficient Colon Cancer
by: Yat-Fung Chow, et al.
Published: (2023-10-01)

Successful Neoadjuvant Therapy with Pembrolizumab Monotherapy for Advanced Ascending Colon Cancer
by: Chien-Tzu Huang*, et al.
Published: (2023-07-01)

Frequency and Molecular Characteristics of Mismatch Repair-deficient Status among Multiple Synchronous Colorectal Cancers
by: Kenichi Chikatani, et al.
Published: (2025-01-01)

Effect of RAS mutations and related immune characteristics on the prognosis of patients with MSI-H/dMMR colorectal cancer
by: Yupeng Jiang, et al.
Published: (2025-02-01)

A new peptide inhibitor of C1QBP exhibits potent anti‐tumour activity against triple negative breast cancer by impairing mitochondrial function and suppressing homologous recombination repair
by: Xingxing Li, et al.
Published: (2025-01-01)

Mouse ZGRF1 helicase facilitates DNA repair and maintains efficient fertility
by: Ernest Wee Kiat Lim, et al.
Published: (2025-01-01)

Increased distribution of carbon metabolic flux during de novo cytidine biosynthesis via attenuation of the acetic acid metabolism pathway in Escherichia coli
by: Tong Ye, et al.
Published: (2025-02-01)

Clinical Use of Dostarlimab in Advanced Stage and Recurrent Endometrial Cancer: Patient Selection and Perspectives
by: Bujnak AC, et al.
Published: (2025-01-01)

Neoadjuvant immunotherapy for DNA mismatch repair proficient/microsatellite stable non-metastatic rectal cancer: a systematic review and meta-analysis
by: Huan Zhang, et al.
Published: (2025-01-01)

Context effects on repair of 5′‐overhang DNA double‐strand breaks induced by Cas12a in Arabidopsis
by: Sébastien Lageix, et al.
Published: (2024-10-01)

Synergistic effect of inhibiting CHK2 and DNA replication on cancer cell growth
by: Flavie Coquel, et al.
Published: (2025-01-01)

Harnessing Machine Learning and Nomogram Models to Aid in Predicting Progression-Free Survival for Gastric Cancer Patients Post-Gastrectomy with Deficient Mismatch Repair(dMMR)
by: Yifan Li, et al.
Published: (2025-01-01)

A comprehensive pan-cancer analysis of RNF187 in human tumors
by: Xuezhong Zhang, et al.
Published: (2025-01-01)

Editorial: Exploring novel approaches to small molecule kinase inhibitors in cancer treatment
by: Anna Carbone, et al.
Published: (2025-02-01)

Colon Cancer Genetic and Epigenetic Changes, Etiopathogenesis, Risk Factors, Treatment: Literature Review
by: Gabrielė Ūbaitė, et al.
Published: (2024-06-01)

A pan-cancer analysis: predictive role of ZNF32 in cancer prognosis and immunotherapy response
by: Minghan Li, et al.
Published: (2025-01-01)

DNA repair in cancer stem cells as a factor for glioma resistance to radiotherapy
by: Yu. S. Makusheva, et al.
Published: (2015-07-01)

Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of PDGFB
by: Bai Y, et al.
Published: (2025-01-01)

Foldback Intercoil DNA and the Mechanism of DNA Transposition
by: Byung-Dong Kim
Published: (2014-09-01)

Homologous recombination deficiency test validation in patients with high-grade advanced ovarian cancer
by: Angelica Nogueira Rodrigues, et al.
Published: (2025-02-01)

Whole exome sequencing-based homologous recombination deficiency test for epithelial ovarian cancer
by: Ying-Cheng Chiang, et al.
Published: (2025-01-01)

A generative deep neural network for pan-digestive tract cancer survival analysis
by: Lekai Xu, et al.
Published: (2025-01-01)

Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer?
by: Tommaso Porcelli, et al.
Published: (2025-02-01)

Eradication of Krebs-2 primary ascites via a single-injection regimen of cyclophosphamide and double-stranded DNA
by: E. A. Potter, et al.
Published: (2016-12-01)

Increased Vitamin B12 Levels in Patients with Oral Cancer
by: Prashant Gupta, et al.
Published: (2023-04-01)

Pan-cancer characterization of m6A-mediated regulation of T cell exhaustion dynamics and clinical relevancies in human cancers
by: Weiping Ji, et al.
Published: (2025-03-01)

Pan-cancer analysis and single-cell analysis identifies the CENPN as a biomarker for survival prognosis and immunotherapy
by: Nie Zhang, et al.
Published: (2025-01-01)

Differentiation of Lynch syndrome from other forms of non-polyposis colorectal cancer among Russian patients
by: A. S. Tsukanov, et al.
Published: (2014-08-01)

Pan-Cancer Analysis of Disulfidptosis-Related Genes Affecting Prognosis and Tumor Microenvironment
by: Jingyang SUN, et al.
Published: (2025-01-01)

Comprehensive pan-cancer analysis reveals NTN1 as an immune infiltrate risk factor and its potential prognostic value in SKCM
by: Fuxiang Luan, et al.
Published: (2025-01-01)

Pan-cancer analysis of the transcriptional expression of histone acetylation enzymes in solid tumors defines a new classification scheme for gliomas
by: Junhao Zhang, et al.
Published: (2025-01-01)

Pan-cancer analysis shows that TNFSF4 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including liver cancer
by: Zhaoda Deng, et al.
Published: (2025-01-01)

Pan-cancer analysis of SOX2: Prognostic implications and potential as a therapeutic target in immune checkpoint modulation
by: Shoukai Yu, et al.
Published: (2025-02-01)

Carboplatin-resistance-related DNA damage repair prognostic gene signature and its association with immune infiltration in breast cancer
by: Shuwen Dong, et al.
Published: (2025-01-01)